megestrol acetate has been researched along with Prostatic Neoplasms in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (42.22) | 18.7374 |
| 1990's | 18 (40.00) | 18.2507 |
| 2000's | 6 (13.33) | 29.6817 |
| 2010's | 2 (4.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, H; Hong, JH; Hong, S; Jeong, IG; Kim, CS; Lee, JL; You, D | 1 |
| Kaore, SN; Langade, DK; Sharma, P; Sharma, R; Thawani, VR; Yadav, VK | 1 |
| OH, WK | 1 |
| Fochessati, F; Panzini, I; Poggi, B; Ravaioli, A; Sartori, S; Tassinari, D | 1 |
| Baum, N | 1 |
| Baum, NH; Torti, DC | 1 |
| Lajiness, MJ | 1 |
| Albert, JD; Geller, J | 3 |
| Canetta, R; Florentine, S; Hunter, H; Lenaz, L | 1 |
| Soloway, MS | 2 |
| Dawson, NA; McLeod, DG | 1 |
| Dose, AM; Fischer, T; Hatfield, AK; Johnson, C; Klatt, NE; Loprinzi, CL; Michalak, JC; Nelimark, RA; O'Fallon, JR; Quella, SK | 1 |
| Smith, JA | 1 |
| McLeod, DG | 1 |
| Akerley, WL; Stein, BS; Wehbe, TW | 1 |
| DeKrey, WL; Finck, G; Fischer, T; Loprinzi, CL; Pierson, N; Pisansky, T; Quella, SK; Sloan, JA; Vaught, NL | 1 |
| Gallo Rolania, FJ | 1 |
| Diamandis, EP | 1 |
| Dawson, NA; Vogelzang, NJ; Vollmer, RT | 1 |
| Burch, PA; Loprinzi, CL | 1 |
| Eastham, JA; Sartor, O | 1 |
| Conaway, M; Dawson, NA; Halabi, S; Lake, D; Small, EJ; Vogelzang, NJ; Winer, EP | 1 |
| Curley, T; Dershaw, DD; Petrylak, D; Scher, HI; Seidman, AD | 1 |
| Venner, P | 1 |
| Geller, J | 3 |
| Daniel, F; MacLeod, PM; Tyrrell, CJ | 1 |
| Hahn, RG; Kvols, LK; Levitt, R; Patel, SR; Therneau, T; Windschitl, H | 1 |
| Venner, PM | 1 |
| Padilla, GM; Padilla, JJ; Payne, B; Petrow, V; Yacullo, RC | 1 |
| Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
| Labrie, F; Lapointe, S; Plante, M | 1 |
| Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L | 1 |
| Sogani, PC; Whitmore, WF | 1 |
| Fair, WR; Sogani, PC | 1 |
| McLeod, DG; Murphy, GP; Priore, R | 1 |
| Hickey, D; Soloway, MS; Todd, B | 1 |
| Babaian, RJ; Johnson, DE; Swanson, DA; Tenney, D; von Eschenbach, AC; Wishnow, KI | 1 |
| Davis, IR; Klotz, LH; Klotz, PG; Orovan, WL; Ramsey, EW; Stewart, DJ; Venner, PM | 1 |
| Crombie, C; Dalley, D; Devine, R; Page, J; Raghavan, D; Rosen, M; Woods, R | 1 |
| Anderson, K; Block, M; Bonomi, P; Bunting, N; Harris, J; Pessis, D; Rossof, A; Slayton, R; Wolter, J | 1 |
10 review(s) available for megestrol acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
Novel actions of progesterone: what we know today and what will be the scenario in the future?
Topics: Animals; Brain Diseases; Brain Injuries; Contraceptive Agents, Male; Female; Humans; Male; Megestrol Acetate; Norethindrone; Osteoporosis; Progesterone; Progestins; Prostatic Hyperplasia; Prostatic Neoplasms | 2012 |
Secondary hormonal therapies in the treatment of prostate cancer.
Topics: Adrenal Cortex Hormones; Androgen Antagonists; Anilides; Biomarkers, Tumor; Disease Progression; Estrogens; Humans; Male; Megestrol Acetate; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Tosyl Compounds | 2002 |
Managing hot flashes in men being treated for prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Complementary Therapies; Cyclohexanols; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Megestrol Acetate; Orchiectomy; Prostatic Neoplasms; Testosterone; Venlafaxine Hydrochloride | 2007 |
Megestrol acetate.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Kidney Neoplasms; Kinetics; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Uterine Neoplasms | 1983 |
Antiandrogenic drugs.
Topics: Androgen Receptor Antagonists; Anilides; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Megestrol; Megestrol Acetate; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 1993 |
Megestrol acetate in the treatment of metastatic carcinoma of the prostate.
Topics: Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prostatic Neoplasms | 1992 |
Megestrol acetate: clinical experience.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms | 1989 |
Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
Topics: Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms | 1988 |
Adrenal androgen blockade in relapsed prostate cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Castration; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Prostate; Prostatic Neoplasms | 1985 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
13 trial(s) available for megestrol acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
Megestrol acetate.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Kidney Neoplasms; Kinetics; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Uterine Neoplasms | 1983 |
Megestrol acetate for the prevention of hot flashes.
Topics: Breast Neoplasms; Climacteric; Double-Blind Method; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1994 |
A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
Topics: Aged; Androgen Antagonists; Clonidine; Diethylstilbestrol; Ergotamine; Flushing; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Orchiectomy; Phenobarbital; Prostatic Neoplasms | 1994 |
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes.
Topics: Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hot Flashes; Humans; Male; Megestrol Acetate; Prostatic Neoplasms | 1998 |
The dynamics of prostate specific antigen in hormone refractory prostate carcinoma: an analysis of cancer and leukemia group B study 9181 of megestrol acetate.
Topics: Antineoplastic Agents, Hormonal; Humans; Male; Megestrol Acetate; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 1998 |
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Humans; Lymphatic Metastasis; Male; Megestrol Acetate; Prostatic Neoplasms; Quality of Life; Survival Rate | 2000 |
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.
Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Diethylstilbestrol; Estramustine; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Vinblastine | 1992 |
Megestrol acetate in relapsed carcinoma of prostate.
Topics: Carcinoma; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Orchiectomy; Prostatic Neoplasms | 1990 |
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
Topics: Aged; Aged, 80 and over; Dexamethasone; Drug Evaluation; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Multicenter Studies as Topic; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate | 1990 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
Comparison of Megace, Stilphostrol, Megace plus DES, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Random Allocation; Streptozocin | 1988 |
Medical castration using megestrol acetate and minidose estrogen.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Cardiovascular Diseases; Clinical Trials as Topic; Diethylstilbestrol; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Time Factors | 1988 |
Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Diethylstilbestrol; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
24 other study(ies) available for megestrol acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cachexia; Castration; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Megestrol Acetate; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Taxoids | 2013 |
Rapid progression of advanced "hormone-resistant" prostate cancer during palliative treatment with progestins for cancer cachexia.
Topics: Aged; Antineoplastic Agents, Hormonal; Cachexia; Disease Progression; Drug Resistance, Neoplasm; Humans; Male; Megestrol Acetate; Palliative Care; Prostatic Neoplasms; Time Factors | 2003 |
How to manage hot flashes in prostate cancer?
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Belladonna Alkaloids; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Combinations; Ergotamines; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Methysergide; Middle Aged; Phenobarbital; Prostatic Neoplasms | 2003 |
Megestrol acetate for the treatment of hot flashes in men undergoing hormone ablation therapy or orchiectomy.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Hot Flashes; Humans; Male; Megestrol Acetate; Orchiectomy; Prostatic Neoplasms | 2007 |
Comparison of various hormonal therapies for prostatic carcinoma.
Topics: Androgen Antagonists; Androgens; Antineoplastic Combined Chemotherapy Protocols; Binding, Competitive; Castration; Dihydrotestosterone; Estradiol; Humans; Male; Megestrol; Megestrol Acetate; Palliative Care; Prolactin; Prostatic Neoplasms; Receptors, Androgen; Testosterone | 1983 |
Newer methods of hormonal therapy for prostate cancer.
Topics: Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1984 |
Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
Topics: Aged; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome | 1995 |
Prostate-specific antigen response to withdrawal of megestrol acetate in a patient with hormone-refractory prostate cancer.
Topics: Antineoplastic Agents, Hormonal; Humans; Male; Megestrol Acetate; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms | 1997 |
[Evaluation of megestrol acetate as monotherapy in disseminated prostatic carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Follow-Up Studies; Humans; Male; Megestrol Acetate; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1998 |
Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Megestrol Acetate; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured; Up-Regulation | 1998 |
Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate.
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Flutamide; Humans; Male; Megestrol Acetate; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms | 1999 |
Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes.
Topics: Aged; GABA Modulators; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Megestrol Acetate; Prostate-Specific Antigen; Prostatic Neoplasms | 1999 |
Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
Topics: Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Testosterone | 1991 |
Therapeutic options in treatment of advanced carcinoma of the prostate.
Topics: Androgen Antagonists; Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms | 1990 |
Melengestrol acetate and megestrol acetate are prostatic tumor inhibiting agents.
Topics: Adrenal Glands; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Male; Megestrol; Megestrol Acetate; Melengestrol Acetate; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Seminal Vesicles | 1990 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
Treatment of prostatic cancer. Newer forms of androgen deprivation.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1986 |
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Megestrol acetate and minidose estrogen in prostatic carcinoma.
Topics: Carcinoma; Drug Therapy, Combination; Estradiol Congeners; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms | 1988 |
Phase II study of megestrol acetate for metastatic carcinoma of the prostate.
Topics: Aged; Humans; Liver; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms | 1987 |
Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer.
Topics: Adrenal Glands; Androgen Antagonists; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Testis | 1985 |
DHT in prostate cancer tissue--a guide to management and therapy.
Topics: Castration; Diethylstilbestrol; Dihydrotestosterone; Humans; Male; Megestrol; Megestrol Acetate; Prognosis; Prostatic Neoplasms | 1985 |
Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
Topics: Aged; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Prognosis; Prostatic Neoplasms | 1985 |